Nine Chapters Capital Management’s Usana Health Sciences USNA Stock Holding History

Nine Chapters Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,600	Closed	-$207K	–	170
2017 Q1	$207K	Buy	+3,600	New	+$215K	0.28%	153
2015 Q4	–	Sell	-34,800	Closed	-$2.33M	–	523
2015 Q3	$2.33M	Buy	34,800 +25,000	+255%	+$1.77M	0.21%	129
2015 Q2	$670K	Buy	+9,800	New	+$622K	0.06%	464
2015 Q1	–	Sell	-6,600	Closed	-$339K	–	1137
2014 Q4	$339K	Buy	+6,600	New	+$324K	0.03%	643
2014 Q2	–	Sell	-9,400	Closed	-$354K	–	1134
2014 Q1	$354K	Buy	+9,400	New	+$328K	0.04%	555

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nine Chapters Capital Management's USNA Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Usana Health Sciences (USNA) in Q2 2017, closing a stake of 3,600 shares — an estimated $207K sold.

Nine Chapters Capital Management first reported a position in USNA in Q1 2014 and held it in 5 quarters. The position peaked at $2.33M in Q3 2015. 145 funds tracked by Wall St. Rank hold USNA as of Q2 2017.

Nine Chapters Capital Management reported no remaining Usana Health Sciences position as of Q2 2017 after selling out during the quarter.
Nine Chapters Capital Management sold 3,600 Usana Health Sciences shares in Q2 2017, an estimated $207K.
Nine Chapters Capital Management first reported a position in Usana Health Sciences in Q1 2014 and held it in 5 quarters.
Nine Chapters Capital Management's Usana Health Sciences position peaked at $2.33M in Q3 2015.
145 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.